Fourpath Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$218K Hold
19,970
– – 0.03% 211
2026
Q2
$183K Hold
19,970
– – 0.02% 227
2026
Q1
$216K Hold
19,970
– – 0.03% 206
2025
Q4
$122K Hold
19,970
– – 0.02% 226
2025
Q3
$103K Hold
19,970
– – 0.01% 227
2025
Q2
$118K Hold
19,970
– – 0.02% 232
2025
Q1
$164K Sell
19,970
-42
-0.2% -$352 0.03% 222
2024
Q4
$165K Hold
20,012
– – 0.03% 225
2024
Q3
$153K Buy
+20,012
New +$184K 0.03% 239

Other funds holding PTEN

Fourpath Capital Management's PTEN Position: Q3 2026 in Review

Fourpath Capital Management held its Patterson-UTI (PTEN) position steady in Q3 2026 at 19,970 shares worth $218K. The position accounts for 0.03% of the portfolio, ranked #211.

Fourpath Capital Management first reported a position in PTEN in Q3 2024 and has held it in 9 quarters since. 42 funds tracked by Wall St. Rank hold PTEN as of Q3 2026.

  • Fourpath Capital Management held 19,970 shares of Patterson-UTI worth $218K as of Q3 2026.
  • Fourpath Capital Management left its Patterson-UTI share count unchanged in Q3 2026.
  • Patterson-UTI made up 0.03% of Fourpath Capital Management's portfolio in Q3 2026, its #211 holding.
  • Fourpath Capital Management first reported a position in Patterson-UTI in Q3 2024 and has held it in 9 quarters since.
  • 42 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.